B-cell regulator of immunoglobulin heavy-chain transcription (Bright)/ARID3a is a direct target of the oncomir microRNA-125b in progenitor B-cells (original) (raw)
Cobaleda C, Sanchez-Garcia I . B-cell acute lymphoblastic leukaemia: towards understanding its cellular origin. Bioessays 2009; 31: 600–609. ArticlePubMed Google Scholar
Calin GA, Dumitru CD, Shimizu M, Bichi R, Zupo S, Noch E et al. Frequent deletions and down-regulation of micro-RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia. Proc Natl Acad Sci USA 2002; 99: 15524–15529. ArticleCASPubMedPubMed Central Google Scholar
Bartel DP . MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 2004; 116: 281–297. ArticleCASPubMed Google Scholar
Shi XB, Xue L, Yang J, Ma AH, Zhao J, Xu M et al. An androgen-regulated miRNA suppresses Bak1 expression and induces androgen-independent growth of prostate cancer cells. Proc Natl Acad Sci USA 2007; 104: 19983–19988. ArticleCASPubMedPubMed Central Google Scholar
Bousquet M, Quelen C, Rosati R, Mansat-De Mas V, La Starza R, Bastard C et al. Myeloid cell differentiation arrest by miR-125b-1 in myelodysplastic syndrome and acute myeloid leukemia with the t(2;11)(p21;q23) translocation. J Exp Med 2008; 205: 2499–2506. ArticleCASPubMedPubMed Central Google Scholar
Zhang H, Luo XQ, Zhang P, Huang LB, Zheng YS, Wu J et al. MicroRNA patterns associated with clinical prognostic parameters and CNS relapse prediction in pediatric acute leukemia. PLoS One 2009; 4: e7826. ArticlePubMedPubMed Central Google Scholar
Gefen N, Binder V, Zaliova M, Linka Y, Morrow M, Novosel A et al. Hsa-mir-125b-2 is highly expressed in childhood ETV6/RUNX1 (TEL/AML1) leukemias and confers survival advantage to growth inhibitory signals independent of p53. Leukemia 2010; 24: 89–96. ArticleCASPubMed Google Scholar
Sonoki T, Iwanaga E, Mitsuya H, Asou N . Insertion of microRNA-125b-1, a human homologue of lin-4, into a rearranged immunoglobulin heavy chain gene locus in a patient with precursor B-cell acute lymphoblastic leukemia. Leukemia 2005; 19: 2009–2010. ArticleCASPubMed Google Scholar
Chapiro E, Russell LJ, Struski S, Cavé H, Radford-Weiss I, Valle VD et al. A new recurrent translocation t(11;14)(q24;q32) involving IGH@ and miR-125b-1 in B-cell progenitor acute lymphoblastic leukemia. Leukemia 2010; 24: 1362–1364. ArticleCASPubMed Google Scholar
Tassano E, Acquila M, Tavella E, Micalizzi C, Panarello C, Morerio C et al. MicroRNA-125b-1 and BLID upregulation resulting from a novel IGH translocation in childhood B-Cell precursor acute lymphoblastic leukemia. Genes Chromosomes Cancer 2010; 49: 682–687. ArticleCASPubMed Google Scholar
Le MT, Teh C, Shyh-Chang N, Xie H, Zhou B, Korzh V et al. MicroRNA-125b is a novel negative regulator of p53. Genes Dev 2009; 23: 862–876. ArticleCASPubMedPubMed Central Google Scholar
Pottier N, Maurin T, Chevalier B, Puisségur MP, Lebrigand K, Robbe-Sermesant K et al. Identification of keratinocyte growth factor as a target of microRNA-155 in lung fibroblasts: implication in epithelial-mesenchymal interactions. PLoS One 2009; 4: e6718. ArticlePubMedPubMed Central Google Scholar
Puisségur MP, Mazure NM, Bertero T, Pradelli L, Grosso S, Robbe-Sermesant K et al. miR-210 is overexpressed in late stages of lung cancer and mediates mitochondrial alterations associated with modulation of HIF-1 activity. Cell Death Differ 2011; 18: 465–478. ArticlePubMed Google Scholar
Le Brigand K, Robbe-Sermesant K, Mari B, Barbry P . MiRonTop: mining microRNAs targets across large scale gene expression studies. Bioinformatics 2010; 26: 3131–3132. ArticleCASPubMedPubMed Central Google Scholar
Webb CF, Bryant J, Popowski M, Allred L, Kim D, Harriss J et al. The ARID family transcription factor bright is required for both hematopoietic stem cell and B lineage development. Mol Cell Biol 2011; 31: 1041–1053. ArticleCASPubMedPubMed Central Google Scholar
Nixon JC, Ferrell S, Miner C, Oldham AL, Hochgeschwender U, Webb CF . Transgenic mice expressing dominant-negative bright exhibit defects in B1 B cells. J Immunol 2008; 181: 6913–6922. ArticleCASPubMed Google Scholar
An G, Miner CA, Nixon JC, Kincade PW, Bryant J, Tucker PW et al. Loss of Bright/ARID3a function promotes developmental plasticity. Stem Cells 2010; 28: 1560–1567. ArticleCASPubMedPubMed Central Google Scholar
Bousquet M, Broccardo C, Quelen C, Meggetto F, Kuhlein E, Delsol G et al. A novel PAX5-ELN fusion protein identified in B-cell acute lymphoblastic leukemia acts as a dominant negative on wild-type PAX5. Blood 2007; 109: 3417–3423. ArticleCASPubMed Google Scholar
Fazio G, Palmi C, Rolink A, Biondi A, Cazzaniga G . PAX5/TEL acts as a transcriptional repressor causing down-modulation of CD19, enhances migration to CXCL12, and confers survival advantage in pre-BI cells. Cancer Res 2008; 68: 181–189. ArticleCASPubMed Google Scholar
Herrscher RF, Kaplan MH, Lelsz DL, Das C, Scheuermann R, Tucker PW . The immunoglobulin heavy-chain matrix-associating regions are bound by Bright: a B cell-specific trans-activator that describes a new DNA-binding protein family. Genes Dev 1995; 9: 3067–3082. ArticleCASPubMed Google Scholar
Filipowicz W, Bhattacharyya SN, Sonenberg N . Mechanisms of post-transcriptional regulation by microRNAs: are the answers in sight? Nat Rev Genet 2008; 9: 102–114. ArticleCASPubMed Google Scholar
Tili E, Michaille JJ, Calin GA . Expression and function of micro-RNAs in immune cells during normal or disease state. Int J Med Sci 2008; 5: 73–79. ArticleCASPubMedPubMed Central Google Scholar
Tili E, Michaille JJ, Cimino A, Costinean S, Dumitru CD, Adair B et al. Modulation of miR-155 and miR-125b levels following lipopolysaccharide/TNF-alpha stimulation and their possible roles in regulating the response to endotoxin shock. J Immunol 2007; 179: 5082–5089. ArticleCASPubMed Google Scholar
Schickel R, Boyerinas B, Park SM, Peter ME . MicroRNAs: key players in the immune system, differentiation, tumorigenesis and cell death. Oncogene 2008; 27: 5959–5974. ArticleCASPubMed Google Scholar
Chaudhuri AA, So AY, Mehta A, Minisandram A, Sinha N, Jonsson VD et al. Oncomir miR-125b regulates hematopoiesis by targeting the gene Lin28A. Proc Natl Acad Sci USA 2012; 109: 4233–4238. ArticleCASPubMedPubMed Central Google Scholar
O'Connell RM, Chaudhuri AA, Rao DS, Gibson WS, Balazs AB, Baltimore D . MicroRNAs enriched in hematopoietic stem cells differentially regulate long-term hematopoietic output. Proc Natl Acad Sci USA 2010; 107: 14235–14240. ArticleCASPubMedPubMed Central Google Scholar
Scott GK, Goga A, Bhaumik D, Berger CE, Sullivan CS, Benz CC . Coordinate suppression of ERBB2 and ERBB3 by enforced expression of micro-RNA miR-125a or miR-125b. J Biol Chem 2007; 282: 1479–1486. ArticleCASPubMed Google Scholar
Nam EJ, Yoon H, Kim SW, Kim H, Kim YT, Kim JH et al. MicroRNA expression profiles in serous ovarian carcinoma. Clin Cancer Res 2008; 14: 2690–2695. ArticleCASPubMed Google Scholar
Bloomston M, Frankel WL, Petrocca F, Volinia S, Alder H, Hagan JP et al. MicroRNA expression patterns to differentiate pancreatic adenocarcinoma from normal pancreas and chronic pancreatitis. JAMA 2007; 297: 1901–1908. ArticleCASPubMed Google Scholar
Klusmann JH, Li Z, Böhmer K, Kremens B, Vormoor J, Dworzak M et al. miR-125b-2 is a potential oncomiR on human chromosome 21 in megakaryoblastic leukemia. Genes Dev 2010; 24: 478–490. ArticleCASPubMedPubMed Central Google Scholar
Enomoto Y, Kitaura J, Hatakeyama K, Watanuki J, Akasaka T, Kato N et al. TEμ/miR-125b transgenic mice develop lethal B-cell malignancies. Leukemia 2011; 25: 1849–1856. ArticleCASPubMed Google Scholar
Webb CF, Smith EA, Medina KL, Allred L, Kim D, Harriss J et al. Expression of bright at two distinct stages of B lymphocyte development. J Immunol 1998; 160: 4747–4754. CASPubMed Google Scholar
Nixon JC, Rajaiya JB, Ayers N, Evetts S, Webb CF . The transcription factor, Bright, is not expressed in all human B lymphocyte subpopulations. Cell Immunol 2004; 228: 42–53. ArticleCASPubMed Google Scholar
Gururajan M, Haga CL, Das S, Leu CM, Hodson D, Josson S et al. MicroRNA 125b inhibition of B cell differentiation in germinal centers. Int Immunol 2010; 22: 583–592. ArticleCASPubMedPubMed Central Google Scholar
Schotte D, De Menezes RX, Moqadam FA, Khankahdani LM, Lange-Turenhout E, Chen C et al. MicroRNA characterize genetic diversity and drug resistance in pediatric acute lymphoblastic leukemia. Haematologica 2011; 96: 703–711. ArticlePubMedPubMed Central Google Scholar